Načítá se...
Management of bleeding in patients treated with direct oral anticoagulants
BACKGROUND: Recently, a new generation of direct-acting oral anticoagulants (DOACs) with a greater specificity towards activated coagulation factors was introduced based on encouraging results for efficacy and safety in clinical studies. An initial limitation of these new drugs was the absence of an...
Uloženo v:
| Vydáno v: | Crit Care |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4992194/ https://ncbi.nlm.nih.gov/pubmed/27543264 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13054-016-1413-3 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|